NEW YORK (AP) — NEW YORK (AP) — Seelos Therapeutics, Inc. (SEEL) on Tuesday reported a loss of $2.7 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of 20 cents.
The drugmaker posted revenue of $579,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SEEL at https://www.zacks.com/ap/SEEL
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
